Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients

Despite the availability of new antifungal compounds, invasive fungal infection remains a significant cause of morbidity and mortality in children and adults undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT recipients suffer from a long lasting defect of differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehrnbecher, Thomas, Schmidt, Stanislaw, Tramsen, Lars, Klingebiel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566394/
https://www.ncbi.nlm.nih.gov/pubmed/23404543
http://dx.doi.org/10.3389/fonc.2013.00017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566394/
https://www.ncbi.nlm.nih.gov/pubmed/23404543
http://dx.doi.org/10.3389/fonc.2013.00017

Ejemplares similares